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The history of prediction and discovery of stem cells is briefly described in the article. The 
analysis of changes in ideas about the nature, functions, and status of mesenchymal stem cells 
(MSCs) in the organism, based on the data of the studies on MSCs published at different times, 
is presented. A hypothesis about MSCs as transient states of different cells was formulated. 
According to their functions the cells provide the reparation of the tissues (by programmed 
replacement of the dying or dead cells), and specialized differentiated cells (the induction of 
their renewal from various types of unauthorized damages, the renewal is induced by action 
of the sets of different signal molecules). MSCs participation in the cell cyclic-continuous 
renewal of an organism is being proposed as a new additional function of MSCs. 
The ever-accelerating development of science 
has triggered some current fundamental chan-
ges in the pivotal notions of biology. In fact, 
a qualitatively new picture of the living is be-
ing built now. One of these ever-changing 
cardinal theoretical views (and their practical 
implementation) is the notion, associated with 
the term of “stem cells”. Prior to this, for a 
century and a half, there have been some qui-
et and imperceptible “current” changes in the 
notions, based on actual, yet far from imme-
diately acceptable and unusual, experimental 
data, unobvious application solutions, multi-
fold changing ideas, new concepts, etc. The 
whole history of stem cells and the course of 
the development of this trend has been pre-
sented and analyzed in fine detail in scientific 
literature[1–3].
The onset of the notions which mark the 
beginning of “stem cells” is related to the 
histologist from Saint-Petersburg, Alexandr 
Alexandrovich Maximov, who, early in the 
previous century, voiced his opinion that dur-
ing the person’s lifetime blood corpuscles 
should be constantly formed somewhere, in 
some continuously existing source, and this 
source should be self-supported. Indeed, this 
idea was actually voiced by A. Maximov at 
the conference of hematologists in Berlin in 
1909. However, the origins lie much deeper 
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and have a larger scale. A new term 
“Stammzellen” (“stem cells” in German) and 
the pivotal notions about its meaning were first 
suggested and formulated as far back as in 
1868 by E. Haeckel. Relating it to the embry-
onic development, he indirectly determined 
something, now called “embryonic stem cells”. 
However, the understanding of the fact that 
some initial “stem” cell is in the core of the 
organism development is more than obvious, 
and the idea of “stem cells” and “stemness” 
(without naming these very terms) had previ-
ously been mentioned by R. Virchow and 
A. Weismann The term itself was introduced 
into scientific terminology by embryologists 
T. Boveri and V. Haecker in 1892. Thanks to 
these researchers, it became commonly used 
and universal. As for hematopoietic stem cells, 
the fact of their existence in terms of blood, 
their function and functioning principles were 
developed in detail, even using the term “stem 
cells” by A. Pappenheim in 1896. His map, 
suggested for the origin of blood cells of dif-
ferent types from the stem blood according to 
the stages of their formation and their schemes 
of images, is generally similar to the one, pre-
sented in textbooks and reviews nowadays 
both in principle and in many details. As for 
non-hematopoietic cells, their presence in bone 
marrow was discovered and described by 
J. Cohnheim in 1867 [4]. After wording and 
substantiating the idea of “stem cells” as some 
universal phenomenon, voiced in late century 
before last, there was some very slow motion 
towards studying them. The ideas and notions 
about stem cells were then related only to the 
fundamental sphere of mainly descriptive biol-
ogy. Human biotechnology did not exist even 
in fantasies at the time, and the interest to stem 
cells was only in purely theoretical, descriptive 
and cognitive terms. Later, as the techniques 
of researches were developing, there started 
gradually increasing interest to them, which 
has now got its implementation in one of the 
strategic directions of biology and medicine. 
“Real” stem cells (SCs) in all the complete-
ness of properties, the actual “stem”, out which 
“everything” can originate, are pluripotent 
cells, obtained from the blastocyst. But the 
most intense works are being conducted with 
SCs, existing in the organism in the postnatal 
period.
It has long been believed that during the 
postnatal period the only “stem” (or at least 
the principal) cells in mammals were the ones, 
located in bone marrow. This notion was based 
on the opinion that these cells form “every-
thing” there is in an adult organism – both 
blood corpuscles and, as required, the differ-
entiated cells of solid tissues. It turned out 
later that all the organs have “their own” stem 
cells. They were called “regional cells”, and 
according to their origin – constantly being fed 
from the “main reservoir” – hematopoietic SCs 
of bone marrow [5, 6]. But an evident contra-
diction to this notion occurred pretty soon. 
Although SCs of bone marrow can get differ-
entiated “into everything”, however, the ac-
tual replacement via differentiation into the 
specialized cells of specific tissues and organs 
can frequently (or even as a rule) occur in the 
organism at the expense of “regional” stem 
cells [7]. It turned out later that “regional” SCs 
carry absolutely not the markers, which they 
should have had, if they had originated from 
the hematopoietic cells. Further studies started 
revealing even more differences between dif-
ferent SCs. It was obviously demonstrated in 
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the functional way. For instance, the introduc-
tion of SCs of bone marrow into the brain or 
an eye promotes the repair of the damage. 
However, these SCs do not transform into 
neurons or retina in vivo. At the same time, 
their own “regional” cells do. During sys-
temic introduction (in the course of a research 
or therapeutic procedures), they get accumu-
lated in the lungs and eliminated quickly, and 
when the hematopoietic SCs of bone marrow 
are introduced into the lesion, after a short 
period the introduced cells are either not found 
at all, or rare remaining donor cells are regis-
tered [8]. But in fact it has been proven using 
the whole methodological armor that the he-
matopoietic SCs of bone marrow can actually 
transform into “everything”. At least there are 
very many of such in vitro works which have 
been independently conducted in different 
centers, institutes, and laboratories.
Quickly accumulating experimental mate-
rial and changing notions have brought about 
the change in priorities. In 1966 A. Friendestein 
[9, 10] described fibroblast-like cells, growing 
in culture from bone marrow. At first, they 
were attributed the properties of stroma, where 
“actual” stem cells (the hematopoietic ones) 
exist in bone marrow, therefore these were 
called “mesenchymal stromal cells” – MSCi. 
It turned out later that these stromal cells were 
capable of getting differentiated into other 
types of cells. While they were identified only 
with the niches for “actual” SCs in bone mar-
row, the “stroma nature” seemed obvious. And, 
taking into consideration their intraosseous 
localization, even their ability to get differen-
tiated, which is brought down to the classic 
triad even now – into bone tissue (osteoblasts), 
into cartilage (chondrocytes) and “fat reserves” 
(adipocytes) [11], looked quite logical. So the 
name of these cells was slightly changed, they 
were then called “mesenchymal multipotent 
stromal cells”. But the deeper this “stroma 
nature” was studied as a phenomenon, the bet-
ter the dynamics of the actual state of SCs, the 
processes in them, their markers, structures, 
functions, and other specificities were investi-
gated, the more questions presented them-
selves. Some time later, it became clear that 
the regional SCs did not derive from the he-
matopoietic ones, they were a special compli-
cated and heterogeneous system of populations 
[12]. And the “stromal” cells of bone marrow 
were only its first example, known to science, 
some “pilot sample”. In terms of their nature 
they were all of mesenchymal origin. So they 
were called “mesenchymal” cells. And they 
were all united according to one general, main 
criterion of stemness, the ability to get diffe-
rentiated into other, specialized cells. 
But further improvement of investigations 
of fine mechanisms, processes, and states have 
stimulated the issues about the nature, origin, 
functions and location in the organism, cells, 
united only by the general criterion of “stem-
ness” to require a new level of theoretical 
generalizations about what is to be defined by 
the term “stem cells”. Such a generalization 
does not exist yet. But the problem of “stem 
cells” has actually been raised full-scale, as 
there is a need for some general concept with-
out any inner contradictions, uniting some-
thing that is viewed as embryonic stem cells 
now, fetal stem cells, hematopoietic stem 
cells, “stem cells of bone marrow”, regional 
stem cells, multipotent cells, mesenchymal 
stem/stromal cells, progenitors, committed 
cells, etc.
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For some time it was enough to have some 
general ideas, according to which SCs as such 
were somehow formed in the process of em-
bryogenesis. Having been formed, “immedi-
ately”, since the first days after birth they start 
and during subsequent weeks, months, years 
continue functioning “adequately”. And sure-
ly “their own” SCs, located in different tissues, 
are the closest one to fulfill the “stem” tasks 
in “their” tissues (organs) [1, 13]. These no-
tions may be called “the concept of cells with 
fixed stemness”. These notions looked quite 
persuasive. Everything would have been fine, 
if it were not for new and new emerging and 
quite unusual experimental data about the pro-
cesses, occurring in SCs and in their state, in 
terms of time. These demonstrated that there 
is some “current multidifferentiation”, accord-
ing to which one predecessor may be the origin 
of something, absolutely not corresponding to 
quiet notions of stable stemness. One of the 
examples may be found in the data about orig-
inating from peripheral nerve-associated glia – 
the cells of a tooth, and in the fact that glial 
cells make their contribution into the regen-
eration of teeth [14]. Such observations could 
still have been coordinated by references to 
continuing ontogenesis. After all, such trans-
formations are temporary, terminal, and, as 
much as they are unusual, they are specific in 
their targeted predetermination.
However, a recent decade and a half have 
witnessed the accumulation of materials, evi-
dently demonstrating overall and almost all-
tissue transitoriness of stemness. By that time, 
such transitoriness in the form of epithelial-
mesenchymal transitions (EMT) was described 
for embryogenesis [15, 16]. For embryogen-
esis, with its rapid comprehensive transforma-
tion, growth, differentiation, etc., the transfor-
mations of the epithelial cells into mesenchy-
mal ones and vice versa – (mesenchymal-epi-
thelial transitions – MET), seemed to be quite 
logical. But then there came and still continues 
rapid accumulation of the experimental results, 
testifying to the fact that EMTs take place in 
the postnatal period as well. During the men-
tioned period this very process is bilateral 
too – in addition to EMTs, there are reverse 
transformations – mesenchymal-epithelial 
transitions, when the mesenchymal component 
gets formed from the epithelium and then ful-
fills stem functions, getting transformed into 
the specialized cells of the epithelial line [16–
19]. Such transitions are the implementation 
of something, inherent to embryogenesis, with 
its almost unlimited and universal multipo-
tency, in the organism after birth. But during 
the postnatal period (and only then) there 
comes an additional source (and, thus, the 
mechanism) of stemness. There is a described 
(and studied in rather fine detail) special sub-
population of monocytes – monocyte-derived 
multipotential cells (MOMC), the cells of 
which are capable of getting differentiated in 
vivo into specialized cells of the mesenchymal 
line [20]. And here the notions about the inde-
pendent status of different types of stem cells 
lose their definiteness, which was used as the 
basis for the whole theory of “stem cells”. But, 
actually, complete indefiniteness was brought 
into the notions about SCs by the accumulation 
of experimental material, related to “stem-
ness”, “multi-” and some other “-potency” due 
to the attempts of answering some firstly very 
quiet, simple, and absolutely natural questions 
about the connection between something, oc-
curring in the laboratory in vitro while cultivat-
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ing the cells “in a test-tube”, and its status, 
state (or, more precisely – the state of the same 
ones) prior to the isolation from the organism, 
i.e. in the very organism – in vivo, in natural 
conditions, “actually”. These questions were 
related to all the stem cells, but the problem 
was most urgent during the fundamental study 
and application of the cell fractions, most fre-
quently defined as “mesenchymal stem/stromal 
cells” in the literature. “Everything is clear” 
with them in culture – these are cells with 
minimal mandatory set of markers, fibroblast-
like in their form, capable of differentiating 
into specialized cells (similar to the standard – 
into chondrocytes, osteoblasts, adipocytes) 
[11]. According to these criteria, the isolation 
of MSCs from different tissues of different 
mammals into culture gave similar reprodu-
cible results. Except that they were not found 
in the organism proper. And those unique pub-
lications, describing such things, raised so 
many questions that it was preferred not to 
discuss the results obtained. Still, the experi-
mental material got accumulated, albeit slow-
ly. And today, in the framework of some not 
common theory yet, but a concept with no 
experimentally grounded contradictions, these 
cells (MSCs) are described in the form of some 
state, common for a wide population of cells, 
forming the endothelium of vessels. The main 
source of MSCs in the endothelium is believed 
to be pericytes. Sometimes they are even 
equated, assuming that all MSCs are actually 
pericytes. As for the abovementioned “all”, 
this is just some emotional estimate of the 
authors of such assumptions. However, the 
omnipresence of pericytes and their transfor-
mation into MSCs do not cast any doubts. And 
the essence of pericytes in their “pericyte” 
status and distribution is all-organism-like, 
“Pericytes, also referred to as periendothelial 
cells or Rouget cells, are mural cells that lie 
on the abluminal side of blood vessels, im-
mediately opposed to endothelial cells... 
Specialized pericytes called Ito cells, hepatic 
stellate cells, or hepatic lipocytes exist in the 
liver... ...another specific pericyte, the mesan-
gial cell, is found in the kidney glomerulus... 
In bone marrow, cells exhibiting perycitic 
characteristics are referred to as adventitial 
reticular cells (ARCs) or myoid cells, as they 
express alpha-smooth muscle actin...” [13].
In addition to “pericyte-derivative” MSCs, 
there are also “non-pericyte-like” MSCs [22].
But it turned out later that there are also 
some “pericyte-like” cells, forming MSCs, and 
smooth muscle cells transform into MSCs, etc. 
Actually, almost all the endothelium cells (and 
the ones, interacting with them) can change 
into the MSC status. And as vessels permeate 
all the tissues and organs (except for carti-
lages, bones, nails, some other very specialized 
formations like the lens of the eye), practi-
cally the whole organism is just highly charged 
with the variety of something, even recently 
considered to be a special type of cells, loca-
li zed in some special “niches” [13, 22, 23]. 
These mutual transitions change the essence 
of the notion of “stem cells” and it is very 
clearly determined in the characteristic, given 
to them now: “...thus, blood vessel walls har-
bor a reserve of progenitor cells, which may 
be integral to the origin of the elusive MSCs 
and other related adult stem cells.” [23] The 
change in the notions sounds absolutely obvi-
ously, even in a provocative and demonstrative 
way, in the very terminology: “elusive MSCs”, 
“a reserve of progenitor cells”, which may be 
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integral to the origin of MSC (progenitors of 
stem cells!), etc. It is not SC which is the key 
pillar of everything, but something “non-stem”, 
something, forming SC, which then fulfills 
these “stem” functions after being formed. To 
get a full picture of this “stem-multi-mix”, the 
fraction of blood monocytes, capable of be-
coming “stem-multi-whatever-is needed” is 
placed in the structure of vascular endotheli-
um [20]. And it is absolutely universal and 
unusual for all the modern notions to publish 
the experimental data, described in fine detail 
and strictly registered in documents, about 
brain glial cells generating multipotent me-
senchymal cells [14], the cells of vascular 
adventiata forming neurons and being the po-
tential source of neuronal progenitors during 
post-ischemic restoration of hippocampus [24], 
the cells of blood vessels (pericytes) of brain 
with the potential of neural stem cells [25], 
etc. Due to their omnipresence, conditioned by 
perivascular localization, their restoring effect 
on local injuries is “instant” and omnipresent, 
and due to their inherent properties – it is po-
tentially unlimited. Thus, this is how they are 
being viewed, “...MSCs may serve as site-
regulated “drugstores” in vivo” [26].
As seen in the abovementioned experimen-
tal materials, described in the literature, MSCs 
are formed not only from pericytes, but also 
from other cells, localized in (and forming) 
internal walls of vessels. In addition, the for-
mation of MSCs from special populations of 
white blood cells was described. But fibro-
blasts/myofibroblasts in different tissues may 
also originate from CD34+ of bone marrow 
and some “actual” stem mesenchymal cells, 
localized in bone marrow, colonizing/inhabi-
ting the tissues “from afar” [21]. The “traces” 
of such origin (or overlapping) have been ex-
perimentally discovered. For instance, MSCs 
of adipose tissue (which are MSCs according 
to all the parameters) have a typical marker of 
hematopoietic SC – CD34+ [27]. In their turn, 
fibroblasts, which originated from mesenchy-
mal cells, were also found to be capable of 
multidifferentiation [4]. When the “classic” 
MSCs, isolated from the local site of the orga-
nism were cloned, it turned out that the colo-
nies, obtained from the individual cells of such 
initial material differed among themselves 
when being titrated by markers. The heteroge-
neity, defined in an experimental way, demon-
strated that the cells in the given local sample, 
which are “typical” MSCs according to com-
mon notions, are non-“characteristic”, one-
type for each tissue (organ), populations of 
MSCs, but rather their heterogeneous sets. 
However, according to their cultural properties, 
morphology, structure and other signs during 
their introduction into culture (in the very first 
inoculation, i.e. zero passage) they looked like 
a uniform homogeneous population [4]. 
On average 1 MSC is per 18,000 mono-
nuclear cells in human bone marrow (1/18,000). 
1 ml of bone marrow content has ≈ 65´106 
mononuclear cells. Thus, 1 ml of bone marrow 
contains only 3,555 MSCs (according to 
Muscler). But this is immediate determination. 
In terms of human treatment, the number of 
MSCs in the bone marrow aspirations for la-
bo ratory analyses via inoculations is estimated 
in the framework of therapeutic doses – hun-
dreds of millions per injection. So, if the cells 
are not similar to MSCs, described by their 
morphology, in vivo, they might acquire their 
(that of MSCs) phenotype “immediately” after 
being attached to plastic in culture. And then 
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they openly write that different cells, inocu-
lated on plastic/glass in culture grow seeming-
ly identical. Currently MSCs are defined as a 
phenomenon, conditioned by in vitro cultiva-
tion conditions [28]. If the available experi-
mental data are generalized, they testify to the 
fact that MSCs are not just a special type of 
cells, or a population of different “stem” cells, 
but a transient state of different cells of me-
sen chymal origin (and not always, at that). For 
a researcher, they are unified by their identical 
growth in culture. They are “one-type” for an 
experimentalist, but everything looks different 
for the organism. It is different because these 
cells have to fulfill restoring functions. As for 
restoring functions, they may be fulfilled both 
in the form of classic stemness – the ability to 
get differentiated into different specialized 
cells, and in the form of release, exit, synthesis 
of signaling molecules, structural formation 
therein, etc., ensuring the safety of damaged 
highly specialized cells of organs and tissues. 
But the notion of different- or one-type 
MSCs is further complicated by some special 
phenomenon – MSC polarization. Having oc-
curred “as required”, MSCs are further polar-
ized “as required for the task”. Two types of 
“one-type” (by their origin and main markers) 
MSCs have been described. The first type is 
remarkable for the reconstruction of metabolism 
for maximal biosynthesis (and further release 
into damaged tissues) of signaling, trophic, 
structural macromolecules. The task of these 
MSCs is to support the survival of damaged 
tissues; to remove the formed pro ducts of dam-
aged cells, to stimulate the restoration of dam-
ages. In MSCs of the second type (polarization), 
metabolism is tuned to the differentiation with 
the purpose of replacing dead cells and spatial-
structural restoring of tissue [29]. It is impos-
sible to ensure it all using one constitutive sta-
tus of one type of cells. Thus, statuses, types 
and origin of MSCs are highly heterogeneous. 
In the organism, MSCs are a multitransient 
state, occurring in the tissues from different 
cells of these tissues “as required”. Immediate 
determinations demonstrate that in addition to 
the abovementioned, there actually is some 
small constitutive population in bone marrow, 
but not a “stromal” mesenchymal population, 
rather, the same basic “stem” one, like hemato-
poietic stem cells. These are two types of “ac-
tual” stem cells. The rest of cells in the organism 
are “stem-transient” when required, or “labora-
tory-stem” ones in culture, on plastic or glass 
according to the researcher’s technology.
But the problem of “stem cells” does not 
end here. Additional mutual indefiniteness was 
brought in by some indications to the fact that 
MSCs in the organism are of different origin. 
Some MSCs originate from primary predeces-
sors of blood cells, some – from “wherever-
possible” due to EMT, and some – in the form 
of a special population of cells – originate as 
far as in early embryogenesis, and, further 
enduring multiple transformations, pass into 
the postnatal period of existence in the com-
position of tissues. And nobody has managed 
to even guess which function these classes of 
MSCs, different in their initial origin, have to 
fulfill. But as for culture, either on plastic or 
on glass, in the medium with fetal calf serum, 
they are so alike that all of them are still named 
the same – MSCs – even today. “To radically 
solve all the problems” – not to humor any-
body, but absolutely seriously – there came a 
suggestion to call them all Medicinal Signaling 
Cells (MSCs) [30].
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The next problem of SC problematics is 
their basic duality. The “real” stem cells are 
self-renewable cells and stem cells at the same 
time. The problem of stemness of SC has been 
discussed above. 
Coming from the “very-very” principal 
property of SC as such, which conditions the 
existence of the stem cells proper, their self-
reproduction should be defined by the pro per-
ty, preserving them, – self-renewal. But the 
experimental data demonstrate that “self-re-
newal” is not the monopoly of only one special 
population of cells. It seems like self-renewal 
in the organism is presented much more fre-
quently than stemness.
It was determined that the property of self-
renewal is inherent to other cells, which have 
already been differentiated. This self-renewal 
occurs without any de-differentiation and sub-
sequent differentiation into something different 
from them, into some specialized derivatives. 
The capability of self-renewal is inherent to 
differentiated cells proper. It has been described 
(and studied in the finest detail) for special 
populations of myeloid lineage, which stems 
not from SC of bone marrow, but indepen-
dently from it, from yolk sac (YS). These are 
often equated with macrophages. They are 
Kupffer cells, Langerhans cells of skin, brain 
microglia and pleural macrophages [31]. They 
persist in the adult organism regardless of he-
matopoietic SCs. As of now, this is a pro per ty 
with unexplainable mechanisms – self-renewal 
for deeply differentiated cells, in this immediate 
differentiated status proper. This independence 
is absolute in terms of origin of these cells, 
“These results define a lineage of tissue macro-
phages that derive from the YS and are geneti-
cally distinct from HSC progeny” [32]. These 
are not even unipotent SCs, these are “self-re-
newable”, differentiated and specialized, and 
“parallel-embryonic” cells by their origin, hav-
ing soma, but being localized in soma. They 
originate not from the initial cells, composing 
soma, or the ones, which occurred in it, but from 
the cells, parallel to soma, – from yolk sac. 
Hepatocytes are self-renewable (and self-re-
placeable). One may assume that other “self...” 
cells will be disco ve red as well.
Therefore, the organism contains 
– constitutional SCs with inherent stemness 
and self-renewal; 
– transient stem cells;
– not stem, but constitutively self-renewable 
cells. 
As for MSCs, their heterogeneity has al-
ready been mentioned above. It is especially 
obvious if scientific literature materials are 
brought together into the comparison format 
(Table 1). 
And generally the existence of metazoans 
(humans included) is ensured not by constitu-
tive SCs (though their role is fundamental), 
but rather by wide networks of differentiated 
cells, potentially having these properties.
All these are cells, capable of forming tran-
sient stemness “as required”. These are all 
tissue macrophages, independently coming 
from the yolk sac. This is the embryo line (also 
autonomously from soma, originating from the 
yolk sac), which gives reproductive cells and, 
allegedly, many other types of cells, which 
potentially have the stemness property, not 
identified in them by science yet. As they are 
potentially stem cells, they might not even 
have SCs in the organism – they are their own 
SC “as required”. Their renewal in the orga-
nism also occurs somehow. 
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Summarized experimental data about “stem 
cells” and their transitoriness lead us to the 
new understanding of the cellular dynamics of 
the organism. Different types of cells have 
their potential of transition, formation, produc-
tion of the transient status of MSCs. The “real” 
SCs (their classic variant being hematopoietic 
SCs of bone marrow) are “napping” according 
to their basic status and provided in rest with 
everything necessary for them by the surround-
ing niche cells. And MSC progenitors are con-
stantly fulfilling their tissue “non-MSC” func-
tions. Their potential of any transition to MSC 
is realized only “as required”. As for the po-
tential of different progenitors, it has different 
threshold of realization – in some it is highly 
sensitive to the necessity signals, in others it 
is overcome only in case of major traumas, 
requiring the mobilization of all the possibili-
ties of the organism. But the nature of distribu-
tion for the most realized progenitors of MSCs 
(perivascular space of blood vessels) ensures 
actual saturation of all the organs and tissues 
with them – every time and everywhere. Even 
purely spatially, it provides the opportunity of 
replacing cells, dying according to the “sche-
du le” (self-renewal of the organism), all the 
kinds of local micro injuries and damages. But 
the cells, replaced in such a way, are differen-
tiated MSCs. There may be any differentia-
tion – from very similar one (into fibroblasts) 
to extremely complicated one (into muscular 
or nervous cells). And now these cells, or the 
ones, capable of giving MSCs via EMT (not 
all the types, but many of them, wide-spread 
in the organism), become potential progenitors 
of MSCs – their new “wave”. It changes the 
views about the cellular status of the organism. 
In the essence of this process, there is con-
tinuous cyclic “stem” transitoriness in the or-
ganism (Fig. 1). This transitoriness is not in-
stantaneous, it does not happen for all the 
progenitors of all the organs and tissues at the 
same time. It is implemented differently in 
terms of space and time. But it goes on in all 
the tissues gradually and repeatedly. It is not 
instantaneous locally, but it is continuous in-
tegrally, in the scale of the whole organism as 
a unified entity. As the polarization of MSCs 
leads to the formation of cells with two types 
Table 1. The variants of the diversity in 
mesenchymal stem cells and self-renewable cells
• Initially in soma layout (ectoderma and endoderma).
• The ones that were formed in the process of early 
embryogenesis in soma from neural crest initially as 
mesenchymal cells, which then passed from the embryo 
to postnatal tissues.
• The ones that are being formed during embryogenesis 
in different tissues of different organs due to epithelial-
mesenchymal transitions.
• The ones that are formed in the postnatal period due to 
epithelial-mesenchymal transitions.
• “Ephemeral” ones, like some transient state/derivative 
(also of mesenchymal origin) of “progenitors”.
• Directly from “classic” hematopoietic stem cells.
• Via the chain of transitions from hematopoietic 
mononuclear cells into MSCs.
• The ones that were formed (as a continuous process or 
only in some special variants, which is not clear yet) 
with the properties of stemness as the main function of 
MSC, in the form of MSC2.
• The same, but with the main function of being 
signaling-regulating (with inhibited “stemness”) in the 
form of MSC1.
• Stromal ones – with the function of “stroma”, providing 
for differentiated, specialized and other cells, which may 
be as important as “stemness” proper, but has not been 
studied well yet.
• Specialized ones, which occur during embryogenesis, 
self-renewable and self-replaceable in the postnatal 
period without any stemness properties.
• “Parallel” ones from the yolk sac, self-renewable, but 
not “stem”, specialized ones.
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of self-renewal, the transient cyclic nature of 
MSCs ensures both replacement of the cells, 
which died “according to the schedule” and 
“not according to the schedule”, and the main-
tenance, reparation of damaged and weak cells.
This massive cyclic nature may ensure the 
selection on a massive scale. Whatever has 
been burdened with mutations, will not pass 
the “check” for full value condition and fall 
out of the cyclicity. Actually, the check for full 
value condition is an absolutely necessary 
phenomenon to be fully complied with. During 
the embryogenesis of a female organism, an 
enormous number of ovum predecessors are 
formed. And almost all of them are destroyed. 
Quite a limited number of oocytes, which 
developed from them, come to the sexual ma-
turity. A similar situation (although shifted in 
time and procedure) takes place during onto-
genesis in the male organism, and leukosis 
should also be added here. The mechanisms 
of checking for full value condition are abso-
lutely obscure now. However, the pheno me-
no logy of single cells passing into the repro-
ductive cycle out of many millions of cells has 
been long determined. The same principal 
process – getting rid of inadequate ones – may 
ensure the cyсlicity of MSCs in soma during 
the postnatal period. It is not as massive and 
radical, yet it is continuous. Cell replacement 
using MSCs, “checked” for full value condi-
tion, renewal of damaged ones, are, albeit 
currently hypothetical, yet already experimen-
tally proven in many elements dually restoring 
(MSC1 and MSC2), polyfunctional, universal, 
and all-penetrating special system of preser-
ving, maintaining the organism.
In actual life, it has that fantastically power-
ful and implemented potential of both stemness 
and self-support, ensuring the existence of 
highly organized metazoans for many years 
(and even hundreds of years, for some). As of 
now, only a very small amount out of this 
whole potential is known and used, but the 
possibilities of even this small amount are re-
ally impressive. The detailed study of this 
potential is the next stage of fundamental bio-
lo gy, which will open new horizons of practi-
cal implementation.
REFERENCES 
1. Bianco P, Robey PG, Simmons PJ. Mesenchymal 
stem cells: revisiting history, concepts, and assays. 
Cell Stem Cell. 2008;2(4):313–9.
2. Brunt KR, Weisel RD, Li RK. Stem cells and regen-
erative medicine – future perspectives. Can J Physi-
ol Pharmacol. 2012;90(3):327–35.
3. Maehle AH. Ambiguous cells: the emergence of the 
stem cell concept in the nineteenth and twentieth 
centuries. Notes Rec R Soc Lond. 2011;65(4):359–78.
4. de Girolamo L, Lucarelli E, Alessandri G, Avanzi-
ni MA, Bernardo ME, Biagi E, Brini AT, D’Amico G, 
Fagioli F, Ferrero I, Locatelli F, Maccario R, 
Marazzi M, Parolini O, Pessina A, Torre ML, Italian 
Mesenchymal Stem Cell Group. Mesenchymal stem/
stromal cells: a new ‘’cells as drugs’’ paradigm. 
Efficacy and critical aspects in cell therapy. Curr 
Pharm Des. 2013;19(13):2459–73.
5. Jiang Y, Vaessen B, Lenvik T, Blackstad M, 
Reyes M, Verfaillie CM. Multipotent progenitor 
cells can be isolated from postnatal murine bone 
marrow, muscle, and brain. Exp Hematol. 2002; 
30(8):896–904.
6. Poulsom R, Alison MR, Forbes SJ, Wright NA. Adult 
stem cell plasticity. J Pathol. 2002;197(4):441–56.
7. Boheler KR. Functional markers and the “homoge-
neity” of human mesenchymal stem cells. J Physi-
ol. 2004;554(Pt 3):592.
8. Leibacher J, Henschler R. Biodistribution, migration 
and homing of systemically applied mesenchymal 
stem/stromal cells. Stem Cell Res Ther. 2016;7:7.
75
Amazing MSC – phenomenology, problems, solutions and opportunities
9. Friedenstein AJ, Petrakova KV, Kurolesova AI, 
Frolova GP. Heterotopic of bone marrow. Analysis 
of precursor cells for osteogenic and hematopoi-
etic tissues. Transplantation. 1968;6(2):230–47.
10. Friedenstein AJ, Piatetzky-Shapiro II, Petrakova KV. 
Osteogenesis in transplants of bone marrow cells. 
J Embryol Exp Morphol. 1966;16(3):381–90.
11. Dominici M, Le Blanc K, Mueller I, Slaper-Corten-
bach I, Marini F, Krause D, Deans R, Keating A, 
Prockop Dj, Horwitz E. Minimal criteria for defin-
ing multipotent mesenchymal stromal cells. The 
international society for cellular therapy position 
statement. Cytotherapy. 2006;8(4):315–7.
12. Klimczak A, Kozlowska U. Mesenchymal stromal cells 
and tissue-specific progenitor cells: their role in tissue 
homeostasis. Stem Cells Int. 2016;2016:4285215.
13. da Silva Meirelles L, Caplan AI, Nardi NB. In search 
of the in vivo identity of mesenchymal stem cells. 
Stem Cells. 2008;26(9):2287–99.
14. Kaukua N, Shahidi MK, Konstantinidou C, Dya-
chuk V, Kaucka M, Furlan A, An Z, Wang L, Hult-
man I, Ahrlund-Richter L, Blom H, Brismar H, 
Lopes NA, Pachnis V, Suter U, Clevers H, Thesleff I, 
Sharpe P, Ernfors P, Fried K, Adameyko I. Glial 
origin of mesenchymal stem cells in a tooth model 
system. Nature. 2014;513(7519):551–4.
15. Acloque H, Adams MS, Fishwick K, Bronner-Fras-
er M, Nieto MA. Epithelial-mesenchymal transitions: 
the importance of changing cell state in development 
and disease. J Clin Invest. 2009;119(6):1438–49.
16. Yoshida S, Kato T, Kato Y. EMT Involved in Migration 
of Stem/Progenitor Cells for Pituitary Development 
and Regeneration. J Clin Med. 2016;5(4). pii: E43.
17. Corallino S, Malabarba MG, Zobel M, Di Fiore PP, 
Scita G. Epithelial-to-Mesenchymal Plasticity Har-
nesses Endocytic Circuitries. Front Oncol. 2015;5:45.
18. Germani A, Foglio E, Capogrossi MC, Russo MA, 
Limana F. Generation of cardiac progenitor cells 
through epicardial to mesenchymal transition. J Mol 
Med (Berl). 2015;93(7):735–48.
19. Kalluri R. EMT: when epithelial cells decide to 
become mesenchymal-like cells. J Clin Invest. 
2009;119(6):1417–9.
20. Seta N, Okazaki Y, Miyazaki H, Kato T, Kuwana M. 
Platelet-derived stromal cell-derived factor-1 is 
required for the transformation of circulating mono-
cytes into multipotential cells. PLoS One. 2013;8(9): 
e74246.
21. Ogawa M, LaRue AC, Drake CJ. Hematopoietic 
origin of fibroblasts/myofibroblasts: Its pathophys-
iologic implications. Blood. 2006;108(9):2893–6.
22. Feng J, Mantesso A, De Bari C, Nishiyama A, 
Sharpe PT. Dual origin of mesenchymal stem cells 
contributing to organ growth and repair. Proc Natl 
Acad Sci U S A. 2011;108(16):6503–8.
23. Crisan M, Yap S, Casteilla L, Chen CW, Corselli M, 
Park TS, Andriolo G, Sun B, Zheng B, Zhang L, 
Norotte C, Teng PN, Traas J, Schugar R, Deasy BM, 
Badylak S, Buhring HJ, Giacobino JP, Lazzari L, 
Huard J, Péault B. A perivascular origin for me sen-
chy mal stem cells in multiple human organs. Cell 
Stem Cell. 2008;3(3):301–13.
24. Yamashima T, Tonchev AB, Vachkov IH, Popiva-
nova BK, Seki T, Sawamoto K, Okano H. Vascular 
adventitia generates neuronal progenitors in the 
monkey hippocampus after ischemia. Hippocampus. 
2004;14(7):861–75.
25. Dore-Duffy P, Katychev A, Wang X, Van Buren E. 
CNS microvascular pericytes exhibit multipotential 
stem cell activity. J Cereb Blood Flow Metab. 
2006;26(5):613–24.
26. Caplan AI, Correa D. The MSC: an injury drugstore. 
Cell Stem Cell. 2011;9(1):11–5.
27. Hoogduijn MJ. Are mesenchymal stromal cells im-
mune cells? Arthritis Res Ther. 2015;17:88.
28. Keating A. Mesenchymal stromal cells: new direc-
tions. Cell Stem Cell. 2012;10(6):709–16.
29. Wagner W, Feldmann RE Jr, Seckinger A, Mau-
rer MH, Wein F, Blake J, Krause U, Kalenka A, 
Bürgers HF, Saffrich R, Wuchter P, Kuschinsky W, 
Ho AD. The heterogeneity of human mesenchymal 
stem cell preparations--evidence from simultaneous 
analysis of proteomes and transcriptomes. Exp He-
matol. 2006;34(4):536–48.
30. Caplan AI. What’s in a name? Tissue Eng Part A. 
2010;16(8):2415–7.
31. Hoeffel G, Wang Y, Greter M, See P, Teo P, Malle-
ret B, Leboeuf M, Low D, Oller G, Almeida F, 
Choy SH, Grisotto M, Renia L, Conway SJ, Stan-
ley ER, Chan JK, Ng LG, Samokhvalov IM, 
76
V. A. Kordium, D. M. Irodov
Merad M, Ginhoux F. Adult Langerhans cells derive 
predominantly from embryonic fetal liver mono-
cytes with a minor contribution of yolk sac-derived 
macrophages. J Exp Med. 2012;209(6):1167–81.
32. Schulz C, Gomez Perdiguero E, Chorro L, Szabo-
Rogers H, Cagnard N, Kierdorf K, Prinz M, Wu B, 
Jacobsen SE, Pollard JW, Frampton J, Liu KJ, 
Geissmann F. A lineage of myeloid cells indepen-
dent of Myb and hematopoietic stem cells. Science. 
2012;336(6077):86–90.
Дивовижні МСК – феноменологія, проблеми, 
рішення, можливості
В. А. Кордюм, Д. М. Іродов
У статті коротко наведена історія передбачення і від-
криття стовбурових клітин. На опублікованих в різні 
часи матеріалах з досліджень МСК, розглядається 
зміна уявлень про їхню природу, функції та статус в 
організмі. Сформульовано припущення, що МСК є 
транзиторним станом різних клітин. Вони забезпечують 
репарацію як тканин (заміщаючи ті клітини що відими-
рають вчасно або випадково загиблі) так і високо ди-
ференційованих клітин (індукуючи в них відновлення 
наборами своїх сигнальних структурних молекул при 
різних несанкціонованих порушеннях). Припускається 
функція МСК у клітинному циклічно-безперервному 
оновленні організму, протягом усього життя.
К л юч ов і  с л ов а: МСК, функції, оновлення, репа-
рація.
Удивительные МСК – феноменология, 
проблемы, решения, возможности
В. А. Кордюм, Д. М. Иродов
В статье кратко приведена история предсказания и 
открытия стволовых клеток. На опубликованных в 
разное время материалах по изучению МСК, рассма-
тривается смена представлений об их природе, функ-
циях и статусе в организме.
Сформулировано предположение о том, что МСК 
представляют собой транзиторные состояния различ-
ных клеток. По своим функциям они обеспечивают 
репарацию тканей (замещая планово отмирающие и 
погибшие) и специализированных дифференцирован-
ных клеток (индуцируя в них наборами своих сигналь-
ных структурных молекул восстановление при различ-
ного рода несанкционированных нарушениях). И как 
еще одна функция МСК, предполагается их участие в 
клеточном циклично-непрерывном обновлении орга-
низма, на протяжении всей жизни.
К л юч е в ы е  с л ов а: МСК, функции, обновление, 
репарация.
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